NCT01703260View on ClinicalTrials.gov

Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Nonalcoholic Steatohapatitis
Interventions
DRUG

Roflumilast

Roflumilast dose

DRUG

Pioglitazone

Pioglitazone dose

DRUG

Placebo

Pioglitazone placebo-matching dose

DRUG

Placebo

Roflumilast placebo-matching dose

Trial Locations (4)

21202

Baltimore

21401

Annapolis

92118

Coronado

Unknown

Coronado

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY